| Flexion-Distraction Technique (NCT06886334) | Istanbul Medipol University Hospital | 2025-04-02 |
| Evaluation of Postoperative Pain in Cases Undergoing Cataract Surgery Under Topical Versus General Anesthesia (NCT07287683) | Alexandria University | 2025-04-02 |
| An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors (NCT06487624) | FBD Biologics Limited | 2025-04-02 |
| Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NCT06536049) | Yazeed Sawalha | 2025-04-02 |
| A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035) (NCT06880874) | Merck Sharp & Dohme LLC | 2025-04-02 |
| The Effects of Cannabis on Male Reproductive Functions (NCT06755346) | Kanako Hayashi | 2025-04-01 |
| A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors (NCT06947226) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2025-04-01 |
| Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma (NCT06913192) | Xuzhou Medical University | 2025-04-01 |
| Vancomycin Dose Optimization in Obesity (NCT06601257) | University of Michigan | 2025-04-01 |
| Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye (NCT06921525) | Ehab Mohamed Elsayed Mohamed Saad | 2025-04-01 |
| Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer. (NCT06888674) | Zhejiang University | 2025-04-01 |
| A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia (NCT06651515) | Seraxis | 2025-04-01 |
| MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas (NCT06712875) | Ann & Robert H Lurie Children's Hospital of Chicago | 2025-04-01 |
| CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma (NCT06913179) | Xuzhou Medical University | 2025-04-01 |
| CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas (NCT06925464) | Beijing GoBroad Hospital | 2025-04-01 |
| Intraoperative Midazolam on Delirium Outcome of Elderly Patients (NCT06963112) | Chinese PLA General Hospital | 2025-04-01 |
| Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies (NCT06917105) | Tongji Hospital | 2025-04-01 |
| Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia (NCT06498687) | University of Nebraska | 2025-04-01 |
| A Single Ascending Dose of HRS-4029 in Healthy Subjects (NCT06905314) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-04-01 |
| Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia (NCT06917898) | Makassed General Hospital | 2025-04-01 |
| Pharmacologic Augmentation of TMS for Depression With D-serine (NCT06876129) | Mclean Hospital | 2025-04-01 |
| MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation (NCT06825572) | Third Affiliated Hospital, Sun Yat-Sen University | 2025-04-01 |
| Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis (NCT06925607) | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 2025-04-01 |
| BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer (NCT06620029) | BioMimetix JV, LLC | 2025-04-01 |
| A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A (NCT06932705) | Addpharma Inc. | 2025-04-01 |
| Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants (NCT06899334) | University Hospital, Basel, Switzerland | 2025-04-01 |
| A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors (NCT06872580) | Qilu Pharmaceutical Co., Ltd. | 2025-04-01 |
| A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors (NCT06657144) | Coherus Oncology, Inc. | 2025-04-01 |
| Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma (NCT06896396) | Zhiyong Huang | 2025-04-01 |
| To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma (NCT06204991) | Inge Marie Svane | 2025-04-01 |
| Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies (NCT07681141) | First Affiliated Hospital of Fujian Medical University | 2025-04-01 |
| Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC. (NCT06896552) | Rabin Medical Center | 2025-04-01 |
| Physiological Manipulation and Surface Electrical Stimulation in Post Stroke Dysphagia Patients (NCT06840938) | Riphah International University | 2025-04-01 |
| Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism (NCT06858254) | Apeiron Research Center | 2025-04-01 |
| Investigation of the Mechanisms of the Gut-brain Axis in Binge Eating and Obesity. (NCT06823557) | Universidade do Porto | 2025-04-01 |
| Study of SLN12140 in Healthy Adult Participants (NCT06945445) | Linno Pharmaceuticals, Inc. | 2025-04-01 |
| Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease (NCT05685368) | Children's Hospital Los Angeles | 2025-04-01 |
| A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet Formulation (NCT06861413) | Vertex Pharmaceuticals Incorporated | 2025-04-01 |
| The Study of Human Chorionic Gonadotropin (HCG) Activating the Dormant Follicles . (NCT06754332) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2025-04-01 |
| Phase 1B/2 Clinical Trial Assessing the Safety, Tolerability and Preliminary Efficacy of the Intravenous Administration of Allogeneic Placental Mesenchymal Cells for the Preemptive Treatment of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery (NCT06678399) | Kelifarma | 2025-04-01 |
| Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial (NCT06623279) | HuidaGene Therapeutics Co., Ltd. | 2025-04-01 |
| Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT07363486) | First Affiliated Hospital of Fujian Medical University | 2025-04-01 |
| A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies (NCT06894693) | Guangdong Ruishun Biotech Co., Ltd | 2025-04-01 |
| A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors (NCT06906731) | Jiangsu HengRui Medicine Co., Ltd. | 2025-04-01 |
| A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults (NCT06867796) | TrueLab Biopharmaceutical Co., Ltd | 2025-04-01 |
| Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes (NCT06854861) | St. Olavs Hospital | 2025-04-01 |
| BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus (NCT06340750) | Luminary Therapeutics | 2025-04-01 |
| Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors (NCT06612645) | Chulalongkorn University | 2025-04-01 |
| Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy (NCT05936229) | Fred Hutchinson Cancer Center | 2025-04-01 |
| To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors (NCT06948539) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2025-04-01 |
| Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD (NCT06823063) | Shanghai IxCell Biotechnology Co., LTD | 2025-04-01 |
| Opioid Drug Interaction Study (NCT06757140) | Shanna Babalonis, PhD | 2025-04-01 |
| A Study of Oral IRAK-4 Inhibitor CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery in Patients With Melanoma Brain Metastases (NCT05669352) | University of Florida | 2025-04-01 |
| Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer (NCT06622174) | Houda Bahig | 2025-04-01 |
| Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy (NCT06680479) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-04-01 |
| LMT503 First-in-human SAD, MAD, and FE Study (NCT05659953) | Lmito Therapeutics Inc. | 2025-04-01 |
| Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer. (NCT06888648) | Zhejiang University | 2025-04-01 |
| A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies (NCT06914037) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-31 |
| A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer (NCT06592638) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-03-31 |
| Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies (NCT06980116) | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 2025-03-31 |
| A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis (NCT06693908) | Genentech, Inc. | 2025-03-31 |
| Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer (NCT06470282) | University of California, San Francisco | 2025-03-31 |
| BBO-11818 in Adult Subjects With KRAS Mutant Cancer (NCT06917079) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2025-03-31 |
| A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients (NCT06946641) | Shanghai Qilu Pharmaceutical Research and Development Center LTD | 2025-03-31 |
| CT-95 in Advanced Cancers Associated With Mesothelin Expression (NCT06756035) | Context Therapeutics Inc. | 2025-03-31 |
| A Study of PHST001 in Advanced Solid Tumors (NCT06840886) | Pheast Therapeutics | 2025-03-31 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria. (NCT06864507) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2025-03-31 |
| CMTS4520 for Chronic Constipation in Adults (NCT06832137) | The Second Hospital of Nanjing Medical University | 2025-03-31 |
| Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males (NCT06901726) | Shanghai Jiao Tong University School of Medicine | 2025-03-31 |
| Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies (NCT06879340) | University of Kansas Medical Center | 2025-03-31 |
| Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers (NCT05582590) | NexImmune Inc. | 2025-03-31 |
| A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. (NCT06898450) | Nimbus Wadjet, Inc. | 2025-03-31 |
| A Study of MHB118C Injection in Patients With Advanced Solid Tumors (NCT07045454) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-03-31 |
| A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound (NCT07304024) | University of Colorado, Denver | 2025-03-31 |
| tFUS for Memory in mNCD and Healthy Adults (NCT06718140) | Medical University of South Carolina | 2025-03-30 |
| Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) (NCT06792968) | Gedeon Richter Plc. | 2025-03-30 |
| High - Dose Vitamin C Infusion Regimen Based on Pharmacokinetic Characteristics for Patients With Advanced Malignant Solid Tumors (NCT07121036) | Zhongnan Hospital | 2025-03-30 |
| Effect of Feldenkrais Method in Enhancing Postural Control for Patients with Diabetic Polyneuropathy (NCT06904417) | Cairo University | 2025-03-30 |
| To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults (NCT06931327) | AJU Pharm Co., Ltd. | 2025-03-29 |
| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject (NCT06935721) | Beijing Tiantan Hospital | 2025-03-28 |
| A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors (NCT07744763) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2025-03-28 |
| Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery (NCT06767566) | University of Utah | 2025-03-28 |
| Atovaquone Combined With Radiation in Children With Malignant Brain Tumors (NCT06624371) | Emory University | 2025-03-28 |
| A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035) (NCT06903715) | Merck Sharp & Dohme LLC | 2025-03-28 |
| Inflammatory Challenge and Fear (NCT06630884) | University of California, San Francisco | 2025-03-28 |
| Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population (NCT06408857) | Gates Medical Research Institute | 2025-03-28 |
| The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders (NCT06620809) | Tongji Hospital | 2025-03-28 |
| A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas (NCT06882746) | Boehringer Ingelheim | 2025-03-28 |
| Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants (NCT06920693) | Generate Biomedicines | 2025-03-27 |
| A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation (NCT06898385) | Sun Yat-sen University | 2025-03-27 |
| A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects (NCT06846684) | SPARK Biopharma | 2025-03-27 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma (NCT06920901) | Apogee Therapeutics, Inc. | 2025-03-27 |
| A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT06655246) | Kura Oncology, Inc. | 2025-03-27 |
| First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours (NCT06795022) | AstraZeneca | 2025-03-27 |
| Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years (NCT06891417) | Sanofi | 2025-03-27 |
| Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC (NCT06895811) | Shanghai Changzheng Hospital | 2025-03-27 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor. (NCT07260513) | Suzhou Genhouse Bio Co., Ltd. | 2025-03-27 |
| A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation (NCT06818812) | Incyte Corporation | 2025-03-27 |
| RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV (NCT06484335) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2025-03-27 |
| Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus (NCT07136389) | Biocad | 2025-03-27 |